National Bank Of Canada Teva Pharmaceutical Industries LTD Transaction History

National Bank Of Canada

$72.7 Billion
Q3 2024

A detailed history of National Bank Of Canada transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, National Bank Of Canada holds 18,296 shares of TEVA stock, worth $413,855. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,296

Previous 18,296 -0.0%

Holding current value

$413,855

Previous $329,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.81 - $18.96 $19,904 - $23,870	-1,259 Reduced 6.44%	18,296 $329,000
Q2 2024 Aug 02, 2024	SELL	$12.78 - $17.4 $4,639 - $6,316	-363 Reduced 1.82%	19,555 $317,000
Q1 2024 May 13, 2024	SELL	$10.67 - $14.43 $175,873 - $237,849	-16,483 Reduced 45.28%	19,918 $281,000
Q4 2023 Feb 06, 2024	BUY	$8.12 - $10.63 $4,993 - $6,537	615 Added 1.72%	36,401 $380,000
Q3 2023 Oct 10, 2023	SELL	$7.48 - $10.7 $136,323 - $195,007	-18,225 Reduced 33.74%	35,786 $365,000
Q2 2023 Jul 26, 2023	BUY	$7.2 - $9.47 $121,428 - $159,711	16,865 Added 45.4%	54,011 $406,000
Q1 2023 Apr 12, 2023	SELL	$8.36 - $11.37 $263,515 - $358,393	-31,521 Reduced 45.9%	37,146 $328,000
Q4 2022 Jan 24, 2023	SELL	$7.95 - $9.48 $266,571 - $317,873	-33,531 Reduced 32.81%	68,667 $0
Q3 2022 Oct 13, 2022	SELL	$6.86 - $11.95 $13.1 Million - $22.8 Million	-1,907,924 Reduced 94.92%	102,198 $815,000
Q2 2022 Jul 28, 2022	BUY	$7.38 - $10.4 $14 Million - $19.8 Million	1,900,596 Added 1735.29%	2,010,122 $15.1 Million
Q1 2022 May 05, 2022	BUY	$7.33 - $9.39 $10,203 - $13,070	1,392 Added 1.29%	109,526 $1.03 Million
Q4 2021 Jan 24, 2022	BUY	$7.9 - $10.19 $854,258 - $1.1 Million	108,134 New	108,134 $834,000

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Account

National Bank Of Canada Teva Pharmaceutical Industries LTD Transaction History